Speaker Profile
Biography
L7 provides software and services that enable synchronized solutions for science + health. L7’s novel Enterprise Science Platform (L7|ESP) is a scientific process and data management solution that enables life science and healthcare companies to connect people, processes, and systems to accelerate discoveries and drive precision healthcare. Prior to L7 Informatics, Dr. Rangadass was the Chief Strategy Officer at NantHealth following its acquisition of Net.Orange, the company he founded to provide an enterprise-wide platform - Clinical Operating System (cOS) to simplify and optimize care delivery processes in health systems.
Session Abstract – PMWC 2022 Silicon Valley
Track Chairs:
Stephen Kingsmore, Rady Children’s Institute for Genomic Medicine
Kate Kernan, UPMC
The rapid development of genomic sequencing technologies has decreased the cost of genetic analysis to the extent that it seems plausible that genome-scale sequencing could have widespread availability in pediatric care. Genomic sequencing provides a powerful diagnostic modality for patients who manifest symptoms of monogenic disease and an opportunity to detect health conditions before their development. However, many technical, clinical, ethical, and societal challenges should be addressed before such technology is widely deployed in pediatric practice.
Sessions:
- PMWC 2022 Luminary Award Ceremony
- Stephen Kingsmore, Rady Children’s Institute for Genomic Medicine
- Martin Reese, Fabric Genomics - NICU Current State & Future of Whole Genome Sequencing
- Stephen Kingsmore, Rady Children’s Institute for Genomic Medicine - Digital Transformation of Precision Medicine Pathways: A NICU Case Study
- Vasu Rangadass, L7 - Inborn Errors of Immunity in Pediatric Sepsis
- Kate Kernan, UPMC - Neonatal Molecular Precision Medicine and Disease Resilience
- Lawrence Prince, Stanford - Showcase
- Martin Reese, Fabric Genomics
- Madhuri Hegde, PerkinElmer
- Paul Kruszka, GeneDx
- Russell Nofsinger, Rady Children's Inst.